Kaynes Technology India Ltd (KAYNES) is currently trading at 3,615.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Kaynes Technology India Limited is an integrated electronics design, engineering and manufacturing company providing turnkey EMS, PCBA, box‑build, OSAT packaging and ODM product engineering across automotive, industrial (including EV), aerospace, railways, medical and IoT verticals from a network of 22+ global manufacturing facilities and R&D centers. The company reported strong 9M FY26 performance with consolidated revenue of ₹23,837 million (up 37% YoY), EBITDA of ₹3,778 million (up 55% YoY) and an order book of ₹90,722 million, signaling meaningful scale and backlog while net debt remains modest at ~₹6,656 million after recent balance sheet moves. Kaynes is executing a material backward‑integration strategy with commissioned OSAT pilot lines at Sanand, imminent HDI PCB capacity in Chennai and multi‑hundred‑crore capex programs; management cites FSA approval and government subsidy visibility that materially de‑risk capital deployment and accelerate strategic manufacturing capabilities. The revenue mix shows concentrated domestic sales (India 91% of FY25) but diversified vertical exposure: Industrial incl. EV at 54% and Automotive at 27%, while acquisitions (August, Sensonic, Tranzmeo) broaden international footprint and add AI and sensing capabilities supporting higher‑value, differentiated products. Operational risks include elevated net working capital days (139 days in 9M FY26) and receivable concentration timing, but management highlights supply chain finance, receivable discounting and inventory consumption in Q4 as active levers to restore target working capital to 70–85 days and improve OCF.

Over the past 52 weeks, Kaynes Technology India Ltd has traded between a low of ₹2,995.85 and a high of ₹7,705.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Kaynes Technology India Ltd has a market capitalization of approximately 24,212.20. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Kaynes Technology India Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 70.04 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 24,212.20 Cr, Kaynes Technology India Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Kaynes Technology India Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Kaynes Technology India Ltd is 70.04. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The drop followed a weaker-than-expected Q4, broker downgrades (including Elara to ‘Accumulate’ and a reported JPMorgan downgrade), and concerns around disclosures and execution.

InGovern linked the decline to repeated guidance revisions, disclosure lapses, weak cash conversion and working-capital strain, which together eroded investor trust.

FY26 consolidated revenue from operations was ₹3,626.4 crore and net profit was ₹363.9 crore.

The stock fell after Q4 FY26 net profit dropped 21.5% year-on-year and EBITDA margin declined to 15.6%, alongside reports of results missing market estimates and a JPMorgan downgrade.